β2-Microglobulin as a potential factor for the expansion of mesenchymal stem cells
- 23 May 2009
- journal article
- research article
- Published by Springer Science and Business Media LLC in Biotechnology Letters
- Vol. 31 (9), 1361-1365
- https://doi.org/10.1007/s10529-009-0027-0
Abstract
Multipotent mesenchymal stem cells (MSCs) hold great promise in regenerative medicine, but one of the biggest challenges facing for their application is the ex vivo expansion to obtain enough undifferentiated cells. Fetal bovine serum (FBS), which can elicit possible contaminations of prion, virus, zoonosis or immunological reaction against xenogenic serum antigens, still remains essential to the culture formulations. There is an urgent need to identify potential factors for the undifferentiated expansion of MSCs to reduce the use of FBS or eventually replace it. A previously recognized housekeeping gene, β2-microglobulin (β2M), is demonstrated to act as a novel growth factor to stimulate the undifferentiated ex vivo expansion and preserve the pluripotency of adult MSCs from various sources. The use of β2M might have promising implications for future clinical application of MSCs.Keywords
This publication has 23 references indexed in Scilit:
- β2-Microglobulin: emerging as a promising cancer therapeutic targetDrug Discovery Today, 2009
- Mesenchymal stem cells in arthritic diseasesArthritis Research & Therapy, 2008
- Anti–β2-microglobulin monoclonal antibodies induce apoptosis in myeloma cells by recruiting MHC class I to and excluding growth and survival cytokine receptors from lipid raftsBlood, 2007
- β2-Microglobulin Promotes the Growth of Human Renal Cell Carcinoma through the Activation of the Protein Kinase A, Cyclic AMP–Responsive Element-Binding Protein, and Vascular Endothelial Growth Factor AxisClinical Cancer Research, 2006
- Dkk-1-mediated expansion of adult stem cellsTrends in Biotechnology, 2004
- β2-Microglobulin as a negative regulator of the immune system: high concentrations of the protein inhibit in vitro generation of functional dendritic cellsBlood, 2003
- β2-microglobulin as a potential initiator of inflammatory responsesTrends in Immunology, 2003
- β2-microglobulin as a negative growth regulator of myeloma cellsBritish Journal of Haematology, 2002
- Human histocompatibility proteinsImmunological Reviews, 2002
- β 2‐Microglobulin and bone cell metabolismNephrology Dialysis Transplantation, 2001